Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by CreatingApeon Jul 15, 2022 8:50am
148 Views
Post# 34826493

RE:RE:RE:RE:RE:RE:So what if I told you

RE:RE:RE:RE:RE:RE:So what if I told youThank you for this! Thought I was the only one... Would everyone here rather have 7 mil shares traded by algo's up 40 percent pre market and then in the red by the end of the day? I believe the up tick in volume and climbing share price will continue. Like the run up to Trogarzo approval. With some bigger jumps as we get further into the trial and more data/partnerships are released. Everything is falling into place slowly but surely. Spceo I know you are frustrated with the market reaction. But didn't they just hit it out of the park? They kept their word this time and didn't dilute us at all with the financing. Sales are up. and they just hit pretty much your "best case scenario" for once on the efficacy news! Yesterday was a great day! And I know people are writing their frustrations hoping management sees it here... That is probably not the best idea. As a retail investor myself. If I read the press release yesterday and was interested in buying in I would for sure come here and read everything to get a vibe and info from people already invested. And honestly with the negative posts all day yesterday after such fantastic news, I would probably move on. I think we kinda shoot ourselves in the foot with that behavior. But hey, I also wish the SP had doubled yesterday, and it probably should have. But this news took a lot of the risk and stress off of my shoulders and I am very grateful for that. And it may just be the beginning of a steady climb upward in valuation and volume. The science will prevail in the end.
<< Previous
Bullboard Posts
Next >>